Trials / Recruiting
RecruitingNCT05967949
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
A Retrospective (Non-interventional) Clinical Study on the First-line Maintenance Treatment of Peripheral T-cell Lymphoma (PTCL) With Chidamide.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.
Detailed description
The study design belongs to a retrospective study, collecting information on patients with PTCL who were diagnosed and treated with chidamide as maintenance therapy at our center. The collected data includes age, gender, previous treatment regimens, results of auxiliary examinations (such as blood routine, biochemistry, bone marrow cytology, pathology, flow cytometry, NGS, etc.), as well as PET-CT images. The safety and efficacy of Chidemide as first-line maintenance therapy in PTCL will be analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | chidamide | This subset of patients received chidamide as first-line maintenance therapy. |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2026-04-01
- Completion
- 2028-04-01
- First posted
- 2023-08-01
- Last updated
- 2023-08-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05967949. Inclusion in this directory is not an endorsement.